- Home
- CPHI vs MTNB Comparison
CPHI vs MTNB Comparison
Compare CPHI & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPHI
- MTNB
- Stock Information
- Founded
- CPHI N/A
- MTNB 2013
- Country
- CPHI China
- MTNB United States
- Employees
- CPHI N/A
- MTNB N/A
- Industry
- CPHI Biotechnology: Pharmaceutical Preparations
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- CPHI Health Care
- MTNB Health Care
- Exchange
- CPHI Nasdaq
- MTNB Nasdaq
- Market Cap
- CPHI 4.0M
- MTNB 3.6M
- IPO Year
- CPHI N/A
- MTNB N/A
- Fundamental
- Price
- CPHI $0.18
- MTNB $0.60
- Analyst Decision
- CPHI
- MTNB Hold
- Analyst Count
- CPHI 0
- MTNB 1
- Target Price
- CPHI N/A
- MTNB N/A
- AVG Volume (30 Days)
- CPHI 1.8M
- MTNB 962.8K
- Earning Date
- CPHI 11-13-2024
- MTNB 11-13-2024
- Dividend Yield
- CPHI N/A
- MTNB N/A
- EPS Growth
- CPHI N/A
- MTNB N/A
- EPS
- CPHI N/A
- MTNB N/A
- Revenue
- CPHI $5,544,620.00
- MTNB N/A
- Revenue This Year
- CPHI N/A
- MTNB N/A
- Revenue Next Year
- CPHI N/A
- MTNB N/A
- P/E Ratio
- CPHI N/A
- MTNB N/A
- Revenue Growth
- CPHI N/A
- MTNB N/A
- 52 Week Low
- CPHI $0.13
- MTNB $0.48
- 52 Week High
- CPHI $0.60
- MTNB $21.50
- Technical
- Relative Strength Index (RSI)
- CPHI 42.59
- MTNB 46.35
- Support Level
- CPHI $0.19
- MTNB $0.56
- Resistance Level
- CPHI $0.24
- MTNB $0.61
- Average True Range (ATR)
- CPHI 0.04
- MTNB 0.16
- MACD
- CPHI -0.00
- MTNB 0.01
- Stochastic Oscillator
- CPHI 0.00
- MTNB 10.24
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.